2Cullough JM.Granulocyte transfusion.In:Petz LD,Swisher SN,Kleinman S,et al.Clinical practice of transfusion medicine.3rd ed,New York:Churchill Livingstone Inc,1996,425～428
3Caspar CB,Reinhard AS,Burger J,et al.Effective stimulation of donors for granulocytet ransfusions with recombinant methionyl tgrnulocyte colonystimulating factor.Blood,1993,81(11):2866
4Bensinger WI,Price TH,Dale DC,et al.The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis.Blood,1993,81(7):1883
5Strauss RG.Granulocyte transfusions.In:Rossi EC,Simon TL,Moss GS,et al(ed).Principles of transfusion medicine .2nd ed,Baltimore:Williams ＆ Wilkins,1996,321～323
6Bhatia S,Mccullough JJ,Perry EH,et al.Granulocyte transfusion:efficacy in fungal infections in neutropenic patients following bone marrow transplantation.Transfusion,1994,34(3):226
7Nagler A,Naparstek E,Engelhard D.Combined therapy of granulocyte transfusions,intravenous opsonins and antibiotics for gram-negative pneumonia in neutropenic cancer patients.Acta Haematol,1994,91(1):42
8Lee JJ,Chung IJ,Park MR,et al.Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections.Leukemia,2001,15(2):203
9Fernandez J,Pressiani V,Solimano J,et al.Granulocytes transfusion for neutropenic patients.Medicina,2001,61(1):93
10Bodey GP,Rolston KV.Management of fever in neutropenic patients.J Infect Chemother,2001,7(1):1
二级参考文献28
1[1]Moroff G, Luban NLC. The irradiation of blood and blood components to prevent graft-versus-host disease:Technical issues and guidelines.Transfusion Medicine Reviews,1997,11:15
3[3]Anderson KC,Goodnough LT,Sayers M,et al.Variation in blood components irradiation practice:implications for prevention of transfusion-associated graft-versus-host disease.Blood,1991,77:2096
4[4]Polesky HF,Helgeson M.Viability of lymphocytes in stored blood:Respones to phytohemagglutin in and to allogeneic leukocytes.J Lab Clin Med,1970,76:134
5[5]Herve p,Wijdenes J,Bergerat JP,et al.Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibodies (B-B5).Blood,1990,75:1017
6[6]Kita T,Nei J,Matsu T,et al.GVHD after transfusion of stored RBC concentrates in a solution of mannitol,adenine,phosphate,citrate,glucose,and Nacl following trauma.Transfusion,2000,40:297
7[7]Nagumo F,Sano M,Tadano J,et al.HLA-DP class Ⅱantigens in transfusion-associated graft versus host disease.Lancet,1993,342:1424
8[8]Wagenr FF,Flegel WA.Transfusion-associated -graft-versus-host disease:risk due to homozygous HLA haplotypes.Transfusion,1995,35:284
9[9]Rubinstein A,Radl J,Cottier H,et al.Unusual combined immunodeficiency and syndrome exhibiting kappa-IgD paraproteinemia,residual gut-immunity and graft-versus-host reaction after plasma infusion.Acta Paediatr Scand,1973,62:365
10[10]Akahoski M,Takanashi M,Masuda M,et al.A case of transfusion associated graft versus host disease not prevented by white cell-reduction filter.Transfusion,1992,32:169
